Immunity and inflammation in pulmonary arterial hypertension: From pathophysiology mechanisms to treatment perspective
Pulmonary arterial hypertension (PAH) is a severe cardiopulmonary dysfunctional disease, characterized by progressive vascular remodeling. Inflammation is an increasingly recognized feature of PAH, which is important for the initiation and maintenance of vascular remodeling. High levels of various i...
Main Authors: | Ran-ran Wang, Tian-yi Yuan, Jian-mei Wang, Yu-cai Chen, Jiu-liang Zhao, Meng-tao Li, Lian-hua Fang, Guan-hua Du |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-06-01
|
Series: | Pharmacological Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1043661822001839 |
Similar Items
-
Muscle strength is reduced in children with pulmonary arterial hypertension
by: Shari Pepplinkhuizen, et al.
Published: (2023-04-01) -
Perspectives of using pulmonary arterial stiffness indicators to evaluate the prognosis of patients with pulmonary arterial hypertension
by: M.A. SIMAKOVA, et al.
Published: (2018-01-01) -
The Potential Application and Promising Role of Targeted Therapy in Pulmonary Arterial Hypertension
by: Meng-Chien Willie Hsieh, et al.
Published: (2022-06-01) -
Pulmonary Hypertension in Left Heart Diseases: Pathophysiology, Hemodynamic Assessment and Therapeutic Management
by: Zied Ltaief, et al.
Published: (2023-06-01) -
PULMONARY HYPERTENSION IN THYROID DISORDERS
by: Delia Panduru, et al.
Published: (2019-12-01)